Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Egevad

Showing results (81-90 of 379) with videos related to

Pageof 38
Sort By:
Scandinavian Journal of Urology and Nephrology|September 14, 2010
Beta-tubulin III expression in prostate cancerLars Egevad, Alexander Valdman, N Peter Wiklund, et al.
Scandinavian Journal of Urology and Nephrology|July 9, 2008
Atypical stromal hyperplasia of the prostateLars Egevad, Bengt-Erik Carbin, Enrique Castellanos, et al.
The Prostate|May 3, 2002
Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancerPernilla Wikström, Ingela Franck Lissbrant, Pär Stattin, et al.
The American Journal of Surgical Pathology|July 2, 2022
In Reply: Intraductal Carcinoma of the Prostate and Nuclear SizeHemamali Samaratunga, Brett Delahunt, John W Yaxley, et al.
The American Journal of Surgical Pathology|July 15, 2021
Intraductal Carcinoma of the Prostate: Extreme Nuclear Size Is Not a Diagnostic ParameterHemamali Samaratunga, Brett Delahunt, John W Yaxley, et al.
Scandinavian Journal of Urology|July 15, 2016
From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancerHemamali Samaratunga, Brett Delahunt, John Yaxley, et al.
Journal of Surgical Oncology|June 19, 2021
Temporal changes in cause-specific death in men with localised prostate cancer treated with radical prostatectomy: a population-based, nationwide studyFrederik B Thomsen, Hans Garmo, Klaus Brasso, et al.
Scandinavian Journal of Urology|April 29, 2024
Temporal trend in risk of prostate cancer death in men with favourable-risk prostate cancerFrederik F Thomsen, Hans Garmo, Lars Egevad, et al.
Pathology|October 17, 2022
Late recurrence of renal solitary fibrous tumour in the contralateral kidneyHemamali Samaratunga, Tony Gianduzzo, Joanna Perry-Keene, et al.
The Prostate|September 25, 2004
Induction of PSA-specific CTLs and anti-tumor immunity by a genetic prostate cancer vaccineAnna-Karin Roos, Maxim Pavlenko, Jehad Charo, et al.
Pageof 38

Showing results (81-90 of 379) with videos related to

Sort By:
Pageof 38
Scandinavian Journal of Urology and Nephrology|September 14, 2010
Beta-tubulin III expression in prostate cancerLars Egevad, Alexander Valdman, N Peter Wiklund, et al.
Scandinavian Journal of Urology and Nephrology|July 9, 2008
Atypical stromal hyperplasia of the prostateLars Egevad, Bengt-Erik Carbin, Enrique Castellanos, et al.
The Prostate|May 3, 2002
Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancerPernilla Wikström, Ingela Franck Lissbrant, Pär Stattin, et al.
The American Journal of Surgical Pathology|July 2, 2022
In Reply: Intraductal Carcinoma of the Prostate and Nuclear SizeHemamali Samaratunga, Brett Delahunt, John W Yaxley, et al.
The American Journal of Surgical Pathology|July 15, 2021
Intraductal Carcinoma of the Prostate: Extreme Nuclear Size Is Not a Diagnostic ParameterHemamali Samaratunga, Brett Delahunt, John W Yaxley, et al.
Scandinavian Journal of Urology|July 15, 2016
From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancerHemamali Samaratunga, Brett Delahunt, John Yaxley, et al.
Journal of Surgical Oncology|June 19, 2021
Temporal changes in cause-specific death in men with localised prostate cancer treated with radical prostatectomy: a population-based, nationwide studyFrederik B Thomsen, Hans Garmo, Klaus Brasso, et al.
Scandinavian Journal of Urology|April 29, 2024
Temporal trend in risk of prostate cancer death in men with favourable-risk prostate cancerFrederik F Thomsen, Hans Garmo, Lars Egevad, et al.
Pathology|October 17, 2022
Late recurrence of renal solitary fibrous tumour in the contralateral kidneyHemamali Samaratunga, Tony Gianduzzo, Joanna Perry-Keene, et al.
The Prostate|September 25, 2004
Induction of PSA-specific CTLs and anti-tumor immunity by a genetic prostate cancer vaccineAnna-Karin Roos, Maxim Pavlenko, Jehad Charo, et al.
Pageof 38